Pfizer Patents – Key Insights and Stats

Pfizer has a total of 113472 patents globally, out of which 46651 have been granted. Of these 113472 patents, more than 39% patents are active. United States of America is where Pfizer has filed the maximum number of patents, followed by Japan and Europe. Parallelly, USA and UK seems to be the main focused R&D center and USA is the origin country of Pfizer.

In 1849, two German immigrants, Charles Pfizer and his relative Charles F. Erhart, founded the company in New York. It is a multinational pharmaceutical and biotechnology corporation. Pfizer develops and produces medicines and vaccines for immunology, oncology, cardiology, endocrinology, and neurology. As of January 2022, Pfizer has a market cap of $304.66 Billion.

The company has numerous blockbuster drugs or treatments that produce yearly revenues of more than $1 billion each. In 2020, the United States contributed 52 percent of the company’s revenue, China and Japan contributed 6% each, and other nations contributed 36%.

Access to Pfizer’s Patent Information

Pfizer joined 20 of the world’s leading biopharmaceutical companies to form the Patent Information Initiative for Medicines (Pat-INFORMED), a public-private partnership between the World Intellectual Property Organization (WIPO), the International Federation of Pharmaceutical Manufactures (IFPMA), and the World Health Organization (WHO) to make it easier for global drug procurement agencies to access a basic body of patent information and make life-saving treatments available to patients in even less time.

In March 2020, as the scale of the COVID-19 pandemic became apparent, Pfizer partnered with BioNTech to study and develop COVID-19 mRNA vaccine candidates.

In November 2021 Pfizer started a new COVID-19 oral antivirus treatment, known as Paxlovid, which according to a recent study reduces the risk of hospitalisation or death by 89%.

How many patents does Pfizer have?

Pfizer has a total of 113472 patents globally. These patents belong to 27151 unique patent families. Out of 113472 patents, 44271 patents are active.

How many Pfizer patents are Alive/Dead?

Worldwide Patents

Pfizer Patent Portfolio

Patent Families

Pfizer Patents

How Many Patents did Pfizer File Every Year?

Pfizer Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantPfizer Applications FiledPfizer Patents Granted
201126642157
201225642037
201327421781
201422921785
201524021732
201623331666
201717311792
201815721507
201915511396
20208001303
20214391372
20227

How Many Patents did Pfizer File in Different Countries?

Pfizer Worldwide Patents

Countries in which Pfizer Filed Patents

CountryPatents
United States Of America12881
Japan7286
Europe7193
Australia5865
Canada5128
Mexico4865
China4469
Brazil3702
Korea (South)3563
India3220
Germany3190
Spain2702
Taiwan2564
Israel2245
South Africa2059
Argentina1768
Singapore1669
New Zealand1611
Norway1566
Hong Kong (S.A.R.)1558
Malaysia1513
Russia1367
Hungary1244
Denmark1244
Peru1217
Thailand1106
Austria1083
Poland1017
Turkey1015
Viet Nam1000
Portugal964
Eurasian Patent Organization894
Philippines887
Czech Republic718
Slovenia666
Uruguay598
Costa Rica598
Slovakia528
Colombia504
Dominican Republic503
United Kingdom496
Chile492
Ecuador490
Tunisia464
Ukraine461
Guatemala425
African Intellectual Property Organization424
Morocco394
Cyprus388
Panama373
Croatia370
African Regional Industrial Property Organization367
Indonesia338
Georgia319
Mongolia310
Serbia309
Netherlands225
Finland221
Iceland205
Honduras196
El Salvador186
Cuba185
Bulgaria141
Nicaragua139
Lithuania115
Montenegro114
Sweden113
Gulf Cooperation Council103
Estonia103
Yugoslavia/Serbia and Montenegro90
Saudi Arabia81
Ireland73
Algeria66
Luxembourg50
Belarus48
Republic of Moldova44
Greece41
Egypt39
Romania38
France22
Belgium22
Italy19
San Marino18
Jordan18
Latvia15
Bosnia and Herzegovina5
Switzerland4
Tajikistan2
Kyrgyzstan2

Where are Research Centres of Pfizer Patents Located?

Research Centers of Pfizer Patents

What is Pfizer working on?

Right now, Pfizer is prioritizing its research and development efforts in areas where they can make a difference to health and social care burdens: Cardiovascular, metabolic and rare disease, Immunology and inflammation, Neuroscience and pain, Oncology, Vaccines.

10 Best Pfizer Patents

US20040167572A1 is the most popular patent in the Pfizer portfolio. It has received 1409 citations so far from companies like Boston Scientific Scimed, Atrium Medical Corporation, and Ethicon, Inc.

Below is the list of 10 most cited patents of PFIZER:

Publication NumberCount of Citing Patents
US20040167572A11409
US6207646B11174
US6239116B1981
US6194388B1773
US6408336B1736
US6178505B1640
US6301493B1625
US6429199B1624
US7488802B2552
US6682736B1518

Which Companies are using Pfizer Patents to Advance their Research?

If patents or patents from a particular technology area of a company receive a lot of citations, it implies that the technology is being followed and incrementally innovated by the citing companies. It also indicates that citing companies are working on similar and closely related technologies.

The top citing companies in the Pfizer patent portfolio are Boehringer Ingelheim, Novartis and Merck Sharp & Dohme Corp.

List of the top forward citing Companies –

CompanyNumber of Patents
Boehringer Ingelheim95
Novartis61
Merck Sharp & Dohme Corp47
Protia47
Glaxosmithkline44
Concert Pharmaceuticals44
Becton Dickinson42
Genentech33
Amgen31
Samsung28

Count of 102 and 103 Type Rejections based on Pfizer Patents

Blocked Patent Applications by Pfizer

Top pfizer Patents used in Rejecting Most Patent Applications

Patent NumberCount of Rejected Applications
US6603008B1152
US7945452B232
US8642831B219
US6911217B119
US6194000B119
US8709483B218
US7972378B218
US7864161B218
US7896916B217
US20040208910A117
US7815934B216
US7760137B216
US7250037B216
US20080068920A116
US8914410B215

What Percentage of Pfizer US Patent Applications were Granted?

Pfizer (Excluding its subsidiaries) has filed 5037 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 2400 have been granted leading to a grant rate of 71.41%.

Below are the key stats of Pfizer patent prosecution at the USPTO.

Which Law Firms Filed Most US Patents for Pfizer?

Law FirmsTotal ApplicationsSuccess Rate
Pfizer Inc162059.67%
Gregg C Benson58164.41%
Peter C Richardson46482.35%
Paul H Ginsburg23271.67%
Charles J Knuth19377.72%
Zoetis10087.88%
Johnson & Johnson7572.22%
Dr Peter C Richardson6995.83%
Ronald S Courtney58100.00%
Jones Day5553.85%

EXCLUSIVE INSIGHTS COMING SOON!

What are Pfizer’s key innovation segments?

What Technologies are Covered by Pfizer?

The chart below distributes patents filed by Pfizer in different countries on the basis of the technology protected in patents. It also represents the markets where Pfizer thinks it’s important to protect particular technology inventions.

R&D Focus: How Pfizer search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Pfizer?

Updated on April 1, 2022

Was this article helpful?

Leave a Comment